14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene

Preferred Label : 14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene;

MeSH note : has antineoplastic activity; also inhibits Fms-like tyrosine kinase-3; structure in first source;

CISMeF synonym : SB1317; TG02;

Is substance : O;

Details

Origin ID

C570909;

UMLS CUI

C3491008;

MeSH indexing information
- Cyclin-Dependent kinases [MeSH Descriptor]
- janus kinase 2 [MeSH Descriptor]
MeSH term(s) associated for indexing
- Heterocyclic Compounds, 4 or More Rings [MeSH Descriptor]
Record concept(s)
- 14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene [MeSH concept]
- SB1317 [MeSH concept]
- TG02 [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients